Search Results - David Shade

Blood biomarkers for Alzheimer's disease are correlated with treatment outcomes in a randomized trial assessing the effects of escitalopram on agitation by Maansi Barnwal, Sheriza Baksh, David Shade, Abhay Moghekar, Paul B. Rosenberg, Anton P. Porsteinsson, Kostas G. Lyketsos

Get full text

Escitalopram for Agitation in Alzheimer’s Dementia by Tarek K Rajji, Sheriza Baksh, David Shade, Zahinoor Ismail, Amer M. Burhan, Hamid Okhravi, Prasad R Padala, Paul B. Rosenberg, Lon S. S. Schneider, Anton P. Porsteinsson, Constantine G. Lyketsos

Get full text

Uncovering Lipid Biomarkers Linked to Methylphenidate Efficacy in Treating Apathy in Alzheimer's Disease: Insights from the ADMET 2 trial by Myuri Ruthirakuhan, Paul B. Rosenberg, Norman J Haughey, Jacobo Mintzer, Nathan Herrmann, Suzanne Craft, Alan J. Lerner, Allan I. Levey, Prasad R Padala, Anton P. Porsteinsson, Christopher H van Dyck, David Shade, Maya Mills, Krista L Lanctôt

Get full text

Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial) by Lijuan Zeng, Jamie Perin, Alden L. Gross, David Shade, Krista L. Lanctôt, Alan J. Lerner, Jacobo E. Mintzer, Olga Brawman‐Mintzer, Prasad R. Padala, Christopher H. van Dyck, Anton P. Porsteinsson, Suzanne Craft, Allan Levey, Nathan Herrmann, Paul B. Rosenberg

Get full text

Correlation between changes in apathy and cognition in Alzheimer’s disease associated apathy: analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2) by Krushnaa Sankhe, Shankar Tumati, Jamie Perin, Luc Rivet, Danielle Vieira, Paul B. Rosenberg, Nathan Herrmann, David Shade, Alan J. Lerner, Prasad R Padala, Olga Brawman‐Mintzer, Christopher H. van Dyck, Anton P. Porsteinsson, Suzanne Craft, Allan I. Levey, Jacobo Mintzer, Krista L. Lanctôt

Get full text